Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NAC vs Calcium Hydroxide in Necrotic Pulp
NCT05666089Phase 1Unknown
- Sponsor
- Cairo University
- Start
- Feb 2023
- Primary completion
- Feb 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised trial of acetylcysteine in pulp necrosis (2 arms), sponsored by Cairo University. Primary endpoints: Intensity of postoperative pain at 6 hours post-instrumentation, Intensity of postoperative pain at 12 hours post-instrumentation and 6 more. Status: unknown.
02
Drugs
acetylcysteine
03
Conditions
pulp necrosis
Beyond the preview
Go deeper on NCT05666089.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05666089.